{
  "created_at": "2020-11-28T04:30:54.000Z",
  "updated_at": "2021-01-06T08:25:13.110Z",
  "id": "16c66f5a-7daf-45ac-aa7e-ac456677dd6d",
  "labels": "current-affairs,2020-11-29",
  "question": "Which vaccine candidate of Russia, would be produced in India from the beginning of 2021?",
  "option1": "mRNA-1273",
  "option2": "BNT162",
  "option3": "Sputnik V",
  "option4": "ZyCoV-D",
  "option5": "",
  "answer": "Sputnik V",
  "explanation": "The promoter of the Sputnik V vaccine candidate - Russian Direct Investment Fund (RDIF) has entered into an agreement with Hyderabad based company named “Hetero Biopharma”. <br />Under the agreement, the Sputnik V vaccine candidate would be produced in India from beginning of 2021. The Sputnik V vaccine is recently claimed to have reached an efficiency of 91.4% in Phase 3 trials."
}